Skip to main content
Quanta Therapeutics, Inc. logo
SEC Form D filing

Quanta Therapeutics, Inc.

Biotech · Series D · Regulation D 506(b) · CA · Filed June 24, 2026

Websitequantatx.com
Offering amount
$89.1M
Exemption
Reg D 506(b)
Issuer state
CA
Filing date
June 24, 2026
Signature date
June 24, 2026
CIK
0001891891

Summary

Auto-generated

Quanta Therapeutics, Inc. is a biotech company offering $89.1M. Filed 506(b) in CA on 2026-06-24. Form D reports a $89.1M Reg D 506(b) offering from CA, and the issuer name and filed fields support the biotech/series-d classification.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.